Artemis Therapeutics Inc. carries a market capitalization of 55.79M, placing it among publicly traded companies globally.
| Market Cap | 55.79M |
| Enterprise Value | N/A |
Artemis Therapeutics Inc.'s stock has declined approximately -86.72% over the past 52 weeks. The 50-day moving average sits at 0.48, while the 200-day moving average is 1.25.
| Beta (5Y) | N/A |
| 52-Week Price Change | -86.72% |
| 50-Day Moving Average | 0.48 |
| 200-Day Moving Average | 1.25 |
| Average Volume (20 Days) | N/A |
Artemis Therapeutics Inc.'s most recent stock split took place on December 20, 2016 with a 50:1 split ratio.
| Last Split Date | 12/20/2016 |
| Split Ratio | 50:1 |